(Q39110569)

9 September 2017

S6K1 inhibition enhances tamoxifen-induced cell death in MCF-7 cells through translational inhibition of Mcl-1 and survivin (English)

1 reference

9 September 2017

1 reference

1 reference

Sung-Eun Hong

1

1 reference

9 September 2017

Eun-Kyu Kim

2

1 reference

9 September 2017

Hyeon-Ok Jin

3

1 reference

9 September 2017

Hyun-Ah Kim

4

1 reference

9 September 2017

Jin Kyung Lee

5

1 reference

9 September 2017

Jae Soo Koh

6

1 reference

9 September 2017

Hyesil Seol

7

1 reference

9 September 2017

Jong-Il Kim

8

1 reference

9 September 2017

In-Chul Park

9

1 reference

9 September 2017

Woo Chul Noh

10

1 reference

9 September 2017

15 August 2013

1 reference

Cell Biology and Toxicology

9 September 2017

1 reference

9 September 2017

29

1 reference

9 September 2017

273-282

1 reference

9 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s10565-013-9253-2

9 September 2017

0 references

cites work

Molecular mechanism and clinical implications of endocrine therapy resistance in breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Sitosterol-containing lipoproteins trigger free sterol-induced caspase-independent death in ACAT-competent macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

A new mutational AKTivation in the PI3K pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Inhibition of S6K1 enhances glucose deprivation-induced cell death via downregulation of anti-apoptotic proteins in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

The prototypical inhibitor of cholesterol esterification, Sah 58-035 [3-[decyldimethylsilyl]-n-[2-(4-methylphenyl)-1-phenylethyl]propanamide], is an agonist of estrogen receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

21 January 2018

Tamoxifen--what next?

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Nuclear protein 1 induced by ATF4 in response to various stressors acts as a positive regulator on the transcriptional activation of ATF4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Regulation and localization of ribosomal protein S6 kinase 1 isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Phosphorylated S6K1 is a possible marker for endocrine therapy resistance in hormone receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Targeting the mTOR signaling network for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

mTORC1 promotes survival through translational control of Mcl-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Biological determinants of endocrine resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Cholesterol metabolism and resistance to tamoxifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Ras, PI(3)K and mTOR signalling controls tumour cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

The 17q23 amplicon and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

TOR signaling in growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-013-9253-2

10.1007/S10565-013-9253-2

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference